Walleye Trading
TGTX icon

Walleye Trading’s TG Therapeutics TGTX Stock Holding History

Walleye Trading’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$425K Sell
12,800
-19,500
-60% -$581K ﹤0.01% 2697
2025
Q4 		$963K Sell
32,300
-29,000
-47% -$947K ﹤0.01% 2404
2025
Q3 		$2.21M Sell
61,300
-3,500
-5% -$115K ﹤0.01% 1749
2025
Q2 		$2.33M Buy
64,800
+11,400
+21% +$424K ﹤0.01% 1643
2025
Q1 		$2.11M Sell
53,400
-100
-0.2% -$3.37K ﹤0.01% 1603
2024
Q4 		$1.61M Buy
53,500
+13,200
+33% +$379K ﹤0.01% 1829
2024
Q3 		$943K Buy
40,300
+28,700
+247% +$627K ﹤0.01% 2139
2024
Q2 		$206K Buy
11,600
+2,400
+26% +$38.3K ﹤0.01% 3076
2024
Q1 		$140K Buy
9,200
+2,900
+46% +$46.2K ﹤0.01% 3624
2023
Q4 		$108K Sell
6,300
-17,800
-74% -$207K ﹤0.01% 4121
2023
Q3 		$201K Buy
24,100
+5,100
+27% +$71.1K ﹤0.01% 3593
2023
Q2 		$472K Buy
19,000
+10,900
+135% +$282K ﹤0.01% 2787
2023
Q1 		$122K Sell
8,100
-29,000
-78% -$441K ﹤0.01% 3765
2022
Q4 		$439K Sell
37,100
-6,300
-15% -$45.7K ﹤0.01% 2924
2022
Q3 		$257K Buy
43,400
+700
+2% +$4.59K ﹤0.01% 3483
2022
Q2 		$181K Buy
+42,700
New +$267K ﹤0.01% 3759
2022
Q1 		– Sell
-7,100
Closed -$135K – 5912
2021
Q4 		$135K Buy
7,100
+1,700
+31% +$44.1K ﹤0.01% 4208
2021
Q3 		$180K Sell
5,400
-1,800
-25% -$55.7K ﹤0.01% 3970
2021
Q2 		$279K Buy
+7,200
New +$283K ﹤0.01% 3579

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Walleye Trading's TGTX Position: Q1 2026 in Review

Walleye Trading reduced its TG Therapeutics (TGTX) stake by 85% in Q1 2026, selling an estimated $928K and leaving 5,386 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #3175.

Walleye Trading first reported a position in TGTX in Q4 2019 and has held it in 16 quarters since. The position peaked at $1.09M in Q4 2025. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Walleye Trading held 5,386 shares of TG Therapeutics worth $179K as of Q1 2026.
  • Walleye Trading sold 31,155 TG Therapeutics shares in Q1 2026, an estimated $928K.
  • TG Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3175 holding.
  • Walleye Trading first reported a position in TG Therapeutics in Q4 2019 and has held it in 16 quarters since.
  • Walleye Trading's TG Therapeutics position peaked at $1.09M in Q4 2025.
  • 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.